State v. Wescott
CourtSuperior Court of Delaware
Date FiledAugust 12, 2026
Docket2507007277, 2507007410
StatusPublished
📰 News Coverage: Read the LAWS.com news report on this case
Full Opinion
SUPERIOR COURT
of the
STATE OF DELAWARE
Jeffrey J Clark Kent County Courthouse
Resident Judge 38 The Green
Dover, DE 19901
Telephone (302) 735-2111
Mr. Christopher Gardner, DAG Mr. Edward C. Gill, Esquire
Mr. Evan Alban, DAG Law Office of Gill, Welsh, and
Department of Justice Chamberlain, P.A.
102 West Water Street 16 North Bedford Street
Dover, DE 19901 P.O. Box 824
Georgetown, DE 19947
Submitted: July 27, 2026
Decided: August 12, 2026
RE: State v. Garron D. Wescott – I.D. Nos. 2507007277 & 2507007410
Counsel:
The State charges Defendant Garron Wescott with multiple drug dealing offenses
stemming from the seizure of what it alleges to have been cocaine, fentanyl, and a mixture
of the two substances. Under Brady v. Maryland,1 he seeks an order compelling
disclosure of any investigations of, or disciplinary action taken against, the analytical
chemist who tested the evidence.2
1
373 U.S. 83 (1963).
2
In addition to Mr. Wescott’s Brady demand, he sought an order compelling the State (1) to identify all
cases in the State of Delaware where the amount of drugs seized varied from the amount tested by the
State, (2) to identify the duty station of a Trooper whose fingerprint was found on the packaging of the
allegedly illegal substances, and (3) to provide the federal criminal history record of another other
individual whose fingerprints were found on the packaging (who the State does not intend to call as a
witness at trial). At oral argument, Mr. Wescott declined to advance the demand that the State identify
The State responds that it possesses no documents—or information for that
matter—that would be material to the defense or would otherwise constitute Brady
material. On this record, Mr. Wescott identifies no basis to counter those assertions.
Accordingly, the motion is denied for the reasons explained more fully below.
THE BRADY STANDARD’S APPLICATION TO A TRIAL COURT
In Brady v. Maryland, the United States Supreme Court explained that due process
requires prosecutors to disclose exculpatory evidence that is material to a defendant’s
defense and to do so far enough in advance of trial to enable the defendant to put it to
use.3 Brady material is evidence that which, if not disclosed to the defendant, would
undermine confidence in the outcome of the trial.4 In Giglio v. United States, the United
States Supreme Court extended the rule to include impeachment material.5 Accordingly,
a prosecutor must disclose substantive evidence and impeachment material possessed by
the prosecutor, the police, or others acting on the State’s behalf.6
Most of the case law does not directly address how a trial court should examine
Brady demands in the first instance. Rather, it typically examines Brady issues in the
context of postconviction motions, and to a lesser extent, direct appeals. The distinction
between evaluating alleged Brady violations pre-verdict versus post-trial is one of
consequence, however. Namely, a court’s review of a Brady issue on appeal or in a
postconviction motion includes viewing the entire trial record. An available record
all Delaware cases from the past five years where there was a weight discrepancy – a request that was
significantly overbroad in any event. As to the trooper’s identify and location, the State has since
identified him sufficiently to enable Mr. Wescott to subpoena him for trial if he desires. Finally, the State
has also provided the other individual’s federal criminal history in a supplemental production.
Accordingly, the disputes over those requests are deemed withdrawn and overly broad, in part, and moot,
in part.
3
Brady, 373 U.S. at 87.
4
Wilson v. State, 271 A.3d 733, 740 (Del. 2022) (quoting United States v. Bagley, 473 U.S. 667, 678
(1985)).
5
405 U.S. 150, 154-55 (1972).
6
Ray v. State, 280 A.3d 627, 646 (Del. 2022).
2
permits a court to consider the materiality of the evidence. Because no trial record is
available prior to or during a trial, it begs the question of how can a court determine
whether evidence withheld from the defense was important enough to make a difference
at trial?7 That, in turn, raises a further question: should a trial court even evaluate the
materiality of the withheld evidence in a Brady dispute given that evidentiary gap?8
The United States Court of Appeals for the Ninth Circuit is one of the few courts
to have addressed this distinction directly:
[w]hether a jury would ultimately find the evidence convincing and lead to
an acquittal is not the measuring rod here. Because no verdict was rendered,
the usual “retrospective test, evaluating the strength of the evidence after trial
has concluded” does not apply [in the trial context]. “[Rather,] the
retrospective definition of materiality is appropriate only in the context of
appellate review”; thus, “trial prosecutors must disclose favorable
information without attempting to predict whether its disclosure might affect
the outcome of the trial.”9
In summary, the element of materiality under Brady—meaning the withheld
evidence is reasonably likely to make a difference in the result of the trial—must be
examined in an appeal or postconviction review.10 A trial court cannot prospectively
7
See B. Bergman & T. Duncan, Pretrial standard for required disclosure, Everytrial Criminal Defense
Resource Book § 5:5 (May 2026).
8
The Superior Court, as a trial court, must apply Brady v. Maryland in the first instance when a dispute
arises prior to trial. Delaware courts, which includes the undersigned, have inappropriately conflated
the appellate standard of review with the trial standard by attempting a materiality determinization in the
absence of any evidentiary record. See, e.g., State v. Gordon, 2016 WL 7188107, at *1 (Del. Super. Dec.
9, 2016); State v. Wright, 2009 WL 3326717, at *3 (Del. Super. Sept. 30, 2009); State v. Davis, 2007
WL 4234453, at *2 (Del. Super. Nov. 28, 2007),
9
United States v. Bundy, 968 F.3d 1019, 1033 (9th Cir. 2020) (first quoting United States v. Olsen, 704
F.3d 1172, 1183 & 1183 n.3 (9th Cir. 2013)(citing United States v. Safavian, 233 F.R.D. 12, 16 (D.D.C.
2005) for the proposition that “[t]he question before trial is not whether the government thinks that
disclosure of the information or evidence ... might change the outcome of the trial going forward, but
whether the evidence is favorable and therefore must be disclosed”); see also Mills v. Commonwealth,
718 S.W.3d 577, 585-87 (Ky. 2025) (holding, in 2025, as an issue of first impression, that a trial court
must confine its mid-trial Brady analysis to consideration of whether undisclosed evidence was favorable
to the defense and not consider its materiality from a result-changing perspective).
10
In the context of appellate review, whether on direct appeal or on a collateral postconviction review,
the Delaware Supreme Court has consistently applied the same standard to both when considering
3
answer that question, however, absent complete evidentiary context. As a result, the only
practical way to harmonize these Brady analyses over separate stages of the proceedings
is to require the State during the pre-trial and trial stages to disclose all evidence favorable
to the defense. The State should not undertake the exercise of predicting whether it will
likely make a difference in the outcome of the trial.
DISCUSSION
Mr. Wescott’s motion identifies a discrepancy between the weight of the drugs at
the time of the seizure, as recorded by the police, and the amount later tested by the
Division of Forensic Science, Chemistry Unit (hereinafter, “DFS”). He further alleges
that the police identified the drugs differently when seizing them than DFS later
confirmed them to be at the lab. Finally, Mr. Wescott alleges “previous issues” with the
chemist who tested the substances at DFS. All three assumptions combine to provide the
backdrop for Mr. Wescott’s demand for the chemist’s employment and disciplinary
history.
In response, the State denied from the outset that it possessed Brady material
regarding the chemist’s employment history. At the motion hearing, however, the State
conceded that it had not confirmed whether DFS had employment information favorable
to the defense. Since the hearing, the State has produced two affidavits: one from DFS’s
alleged Brady violations. For a violation to have occurred, (1) evidence must exist that is favorable to
the accused, because it is either exculpatory or impeaching; (2) that evidence must have been suppressed
by the State; and (3) the defendant must have suffered prejudice because the State suppressed material
evidence that creates a “reasonable probability that, had the evidence been disclosed to the defense, the
result of the proceeding would have been different.” Gray v. State, 126 A.3d 631, 2015 WL 5926151,
at *3 (Del. Oct. 9, 2015) (TABLE) (direct appeal) (emphasis added); see also Wright v. State, 91 A.3d
972, 988 (Del. 2014) (applying same standard on appeal from the denial of Rule 61 motion).
Furthermore, in cases where Brady material is disclosed mid-trial, a defendant-appellant must also show
that the late-disclosed evidence could not have been used effectively at trial given the timing of the
disclosure. Cooper v. State, 992 A.2d 1236, 2010 WL 1451486, at *1 (Del. 2010) (TABLE). In
assessing prejudice on appeal, courts apply the same prejudice standard articulated in Strickland v.
Washington, 466 U.S. 668 (1984). See United States v. Bagley, 473 U.S. 667, 682 (1985) (holding that
Strickland prejudice standard applies to Brady inquiry regardless of the specificity of the defendant’s
request).
4
director, and one from a human resource official from DFS’s parent agency, the
Department of Safety and Homeland Security. Both affiants attest that the chemist has
never been disciplined for conduct related to her employment or for improper evidence
handling.
Granted, if there was documentation regarding adverse disciplinary action taken
against, or a finding against, a chemist for evidence mishandling, it would constitute
impeachment material that must be disclosed under Brady.11 But here, the State made
reasonable inquiries with (1) the head of the chemist’s agency, and (2) the agency’s human
resources department. Both attested, based on personal knowledge and inquiry, that the
chemist at issue “has never been disciplined for conduct related to her employment [or]
regarding evidence handling.”
Mr. Wescott focuses on a Sussex County Superior Court case, State v. Newcomb,
to support his argument.12 He contends that the chemist in that case—the same chemist
who tested the alleged drugs in his case—was placed on temporary administrative leave
while DFS investigated a discrepancy in drug amounts between seizure and testing.
There, as here, the defendant sought the chemist’s employment records and an
investigative report examining the matter. The State responded in writing that “there were
not any materials responsive to Brady” in any documents in the State’s possession.13
In response to Mr. Wescott’s motion, the State includes the Sussex County Superior
Court’s finding after in camera review of documents in the Newcomb matter. 14 That
letter provides the court’s finding that none of the information required disclosure under
11
See State v. Coverdale, 2017 WL 1405815, at *7 (Del. Super. April 18, 2017) (granting post-conviction
relief where prosecutors falsely stated that State chemist had resigned due to lack of productivity when,
in fact, he had resigned to avoid termination for inappropriate testing procedures and incorrect
identification of drugs while under the threat of disciplinary action).
12
I.D. No. 2506002267 (Del. Super.)
13
D.I. 37 ¶ 5
14
D.I. 37, Ex. C.
5
Brady in that case,15 which is consistent with the affidavits the State submitted in this
case.
Mr. Wescott also relies on the transcripts of two office conferences in separate cases
where counsel discussed alleged evidence mishandling by DFS. Neither transcript belies
the State’s response that it has no documents that qualify as Brady material in Mr.
Wescott’s case, however. Nor do the discussions in those conferences make appropriate
an in camera review of the chemist’s employment files. Again, the prosecutor had a
constitutional and ethical obligation to inquire and evaluate whether DFS possessed
evidence that is favorable to the defense. It firmly represents that the State has no such
information.
Lastly, Mr. Wescott relies on the Superior Court decision in State v. Coverdale in
support of his motion.16 There, in a postconviction relief case examining an alleged Brady
violation, the prosecutor knew that material should have been disclosed prior to trial under
Brady and Giglio but did not.17 The chemist in that case had resigned under the threat of
pending disciplinary action for a series of documented evidence handling infractions. In
Mr. Wescott’s case, there are firm representations that no such disciplinary history exists.18
As a final note, the Court recognizes Mr. Wescott’s proffers (1) that the weights of
the substances seized are different from the weights confirmed at testing by DFS, and (2)
that the types of drugs recorded after field tests by the seizing agency differ from those
15
Id.
16
See Coverdale, 2017 WL 1405815, at *7.
17
Id. at *2-3.
18
To be clear, the State’s representations that there has been no adverse action taken against the chemist
is considered by the Court to encompass a representation that there are no current, unresolved
disciplinary actions pending against the chemist. Such a circumstance, if it was the case, would align
this case more closely with Coverdale. Nevertheless, in contrast to either misconduct findings or pending
disciplinary actions, mere concluded investigations and reviews that discovered no evidence of
misconduct or mistake on the part of the chemist would be too attenuated to constitute Brady material
under the trial standard. Similarly, Mr. Wescott’s request that the State identify all Delaware cases in the
last five years where there was a weight discrepancy between seizure and testing is too broad and
attenuated to constitute Brady material when applying the standard required of a trial court.
6
later confirmed by DFS. To be clear, this decision does not address whether evidence or
questioning regarding these alleged discrepancies can be introduced into evidence or be
used for impeachment purposes at trial. At first blush, they are likely to be fertile ground
for cross-examination of the State’s chemist and the seizing and collecting officers.
Nevertheless, any disputes regarding admissibility of such evidence should be resolved
by the trial judge under D.R.E. 104(a).
CONCLUSION
For the foregoing reasons, Mr. Wescott’s motion to compel production of Brady
material is DENIED.
IT IS SO ORDERED.
Very truly yours,
/s/ Jeffrey J Clark
Resident Judge
7